Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Midday movers: Diamondback Energy rises, Arm goes parabolic

Published 13/02/2024, 03:26 am
Updated 13/02/2024, 03:26 am
© Reuters

(Updated - February 12, 2024 11:21 AM EST)

Investing.com -- Main U.S. indexes edged higher Monday in subdued trading ahead of key inflation data scheduled to be released later this week that could impact the timing of Fed rate cuts.

Here are some of the biggest U.S. stock movers today:

Diamondback Energy (NASDAQ:FANG) rose 10% after announcing an agreement to merge with Endeavor Energy Resources in a transaction valued at approximately $26 billion.

Joby Aviation (NYSE:JOBY) shares rose 7% after the company inked a deal with Dubai's transportation authority to launch its air taxi services in the Emirate by early 2026.

Shares in Rivian (NASDAQ:RIVN) declined 1% after Barclays (LON:BARC) slashed its rating of the electric vehicle group to "equal-weight" from "overweight", citing signs of increased pressure on EV demand.

Monday.com (MNDY (NASDAQ:MNDY)) shares fell 9% after the project management software firm guided for 2024 adjusted operating income that was below analysts’ expectations.

Trimble (TRMB) shares rose 4.7% after fourth quarter EPS and revenue topped consensus, although its forecast trailed estimates.

BioXcel Therapeutics (BTAI) surged 10% after the drugmaker said its treatment for small cell neuroendocrine prostate cancer had received fast track approval from the U.S. Food and Drug Administration.

Marqeta (MQ) shares advanced 5% after analysts at Bank of America (NYSE:BAC) upgraded their rating of the financial services group to "buy" from "neutral".

Citigroup (C) shares slipped 0.2% on a report that U.S. regulators had asked the lender to make urgent changes to the way it measures and controls risk.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

CymaBay Therapeutics (NASDAQ:CBAY) stock rose 25% after Gilead Sciences (NASDAQ:GILD) announced it would acquire the drug developer for $4.3 billion.

Lowe’s Companies (NYSE:LOW) stock rose 3% after analysts at JPMorgan (NYSE:JPM) upgraded its rating to ‘overweight’ from ‘neutral’ and added the stock to its Focus List.

Arm Holdings (NASDAQ:ARM) rose 35% amid ongoing momentum in semiconductor names. Arm is up over 80% since reporting quarterly results. Super Micro Computer (NASDAQ:SMCI) also rose, climbing 7.5%.

Shares of Big Lots (NYSE:BIG) plummeted more than 20% after the retail chain operator said preliminary results for the fourth quarter would be in-line with guidance. Separately, the stock was cut to ‘sell’ with a price target of $1 at Loop Capital. Analysts have doubts about its financial stability.

Teva Pharma (NYSE:TEVA) climbed 6% after analysts at Piper Sandler upgraded the stock to ‘overweight’ from ‘neutral’ with a price target of $19.


Additional reporting by Louis Juricic

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.